âCanât connect the issues… think connective tissueâ
Ever had a patient with so many signs and symptoms that just donât add up? Do you routinely consider hypermobility in your differentials?
Hypermobility can be one of the most challenging and fascinating presentations we see as physiotherapists, and it often goes under the radar. These patients often come to us after years of being misunderstood, misdiagnosed, or told that their symptoms are âjust flexibilityâ or the result of anxiety. Yet, behind their mobility lies a complex interplay of connective tissue, autonomic, and neuromuscular factors that demand a nuanced approach.
In her Case Study, expert on hypermobility Taylor Goldberg takes us through how she identifies hypermobility, assesses for other contributing comorbidities, and ultimately manages the condition to help her patients achieve their goals. Hypermobility is a condition we are all likely to see in the clinic at some point, and itâs important that a) we donât miss it and b) weâre confident in how to manage it! So with that said, Taylorâs Case Study is a must watch. For now, this blog touches on some of the key aspects of hypermobility assessment.
If you want to see exactly how hypermobility expert Taylor Goldberg diagnoses and manages her patients, watch her full Case Study HERE. With Case Studies you can step inside the minds of experts and apply their strategies to get better results with your patients. Learn more here.
First, what is hypermobility?
There are three main types of patients youâll see with hypermobility: ones who already know they have it, those who suspect it (likely due to the increasing attention on social media), or ones that have a bunch of symptoms and no idea they have hypermobility. Understanding which group your patient falls into changes how you communicate and what you focus on during assessment.
While hypermobile Ehlers-Danlos Syndrome (hEDS) might be the most commonly known, there are other types of hypermobility disorders to be aware of. See Taylor explain these types in this clip from her Case Study:
How is hEDS diagnosed?
Taylorâs case involved a 26-year-old female, a former gymnast who had been largely inactive for the past two years. She presented with severe neck pain, chronic fatigue, dizziness, recurrent subluxations, and an overall sense of physical weakness.
She described that no matter how hard she tried, she couldnât build muscle and that exercise often left her wiped out for days. These factors raised Taylorâs suspicion of hEDS. Unlike all other hypermobility disorders, hEDS has no known genetic marker, which makes diagnosis entirely clinical. The process for diagnosing hEDS for this patient included completing a hEDS diagnostic criteria checklist, and referring the patient to a geneticist to test for and rule out all other forms of hypermobility.
Additional to this, other common comorbidities Taylor assessed for included:
- Postural Orthostatic Tachycardia Syndrome (POTS): Often seen with dizziness, palpitations, or a racing heart when standing. This was confirmed in the patient via a tilt-table test.
- Mast Cell Activation Syndrome (MCAS): Patients may report unexplained allergic-type symptoms or medication sensitivities. In this case, the patient was treated with over-the-counter medications which had a positive impact, indicating that MCAS was a likely comorbidity.
- Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Use the DSQ-PEM questionnaire for this. This was used to rule out ME/CFS for this patient.
- Upper cervical instability: Occurs between C1-C2 or C1-the skull, which can compress the brainstem and cause chronic neck pain, dizziness, or a âheavy headâ feeling. Should be ruled out in people with connective tissue disorder and neck symptoms. This was ruled out for Taylorâs patient through the subjective, as the patientâs neck pain was in the upper-trapezius and she did not report a heavy head feeling.
- Anxiety: There is an overlap between anxiety and dysautonomia caused by conditions like POTS, so itâs important to explore whether symptoms like dizziness, breathlessness, or a racing heart occur in response to emotional stress or positional change. A simple question like âwhat position were you in when the symptoms occurred?â can help differentiate the two.
Objective assessment
Taylor completed a comprehensive assessment of the patient, a few key assessments included: full-body active range of motion (looking for hypermobility and guarding), single-leg stance with eyes closed (assessing proprioception), oculomotor assessment, and neurological assessments (due to the patientâs report of dizziness and neck pain – these tests were clear).
Taylor likes to assess compound and accessory movements, including movements that are important to the patientâs goals. See her explain what to look out for in some lower-limb compound movements in the below video from her Case Study:
Additionally, because the patient was reporting neck pain, she assessed a row with a triceps extension, looking at the quality of the movement and the patientâs ability to isolate the muscles; see her explain in the below clip from her Case Study:
Assessing these movements not only gives you an idea of the patientâs current function, but they also form the basis of your treatment planning.
Graded exercise is a core component of the intervention; however, it can be really tricky to understand just what and how much to do with these patients. Taylor uses a really useful traffic light system for movements and activities:
- Red: The movement/activity causes debilitating pain in the moment AND/OR pain lasts for 2 days or more = avoid it for now and build up to it in time.
- Yellow: The movement/activity causes pain which is not debilitating AND/OR pain lasts less than 2 days = we can try to modify this.
- Green: The movement/activity causes no pain/tolerable sensation = okay to do the movement/activity.
This approach helps patients reconnect with movement without fear while respecting their bodyâs thresholds. It turns symptom monitoring into an empowering tool rather than a source of frustration, and thatâs often the key to sustained progress.
Wrapping up
Hypermobility is complex, multifaceted, and misunderstood, often leaving patients feeling alone in managing it. Letâs be clinicians who help patients with hypermobility feel empowered and supported!
With the right clinical lens, it becomes a fascinating puzzle rather than a mystery. From recognising red flags to differentiating between anxiety and dysautonomia, every piece of your assessment matters.
To see how an expert clinician brings all of this together in practice, from detailed assessment to pain strategy implementation, watch Taylorâs full Case Study. Youâll walk away with clear, evidence-informed strategies you can apply in the clinic tomorrow.
đ©ââïž Looking to sharpen your clinical reasoning?
đ Our Case Studies service is here to help!
đ„ Watch case study presentations that reveal how top clinicians treat real patientsâŠ
đ And apply their strategies to get better results with yours!
Donât forget to share this blog!
Leave a comment (1)
If you have a question, suggestion or a link to some related research, share below!
You must be logged in to post or like a comment.
Related blogs
View allElevate Your Physio Knowledge Every Month!
Get free blogs, infographics, research reviews, podcasts & more.
Thank you for the article. I’ve seen a dramatic increase in hypermobility in my practice. Seemingly more since the covid era but that’s a subjective impression. I’ve slowly built my own assessment skills for heds and hypermobility spectrum disorder. My frustration with these conditions is more about methodology of treatment. There seems to be an enormous gap between assessment and efficacious interventions. Strengthening is of course important and biologics like PRP and prolotherapy can help stablilize joints but I can’t help wonder if, despite the vast number of symptoms and the spectrum of severity of the symptoms, there isn’t better treatments and philosophical perspectives available. Possibly dietary or supplemental or electromagnectic. I see so many progressed and severe cases, usually heds, and there seems very little that can be done. Mainstream medicine is very behind on accepting hypermobility as serious health issues much less having a clear picture on the commonality of seemingly disparate symptoms which leads to micro diagnosing which leads to people going to specialists that in effect each see different parts of the elephant without seeing the entire animal. The fascial system with its highly innervated matrix has a far greater impact on the whole body’s metabolic functioning than the current health care paradigm seems willing to consider. Until there’s more research and study a very large demographic of the population is going to suffer for a long time.